Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8776093 | Urology | 2018 | 6 Pages |
Abstract
Urethral adenocarcinoma of males is a rare disease with limited prospective data to define optimal treatment. Surgical excision remains the primary treatment for early-stage disease. Multimodality therapy with a combination of chemotherapy, radiation, or surgery has been explored in patients with locally advanced disease. We present the case of a 45-year-old-man with a locally recurrent urethral adenocarcinoma after initial surgical resection managed successfully with combined weekly cisplatinum and radiation therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Prateek Mendiratta, Brian I. Rini, Rahul D. Tendulkar,